World Journal of Surgery

, Volume 32, Issue 12, pp 2612–2616 | Cite as

Long-Term Changes in Parathyroid Function After Subtotal Thyroidectomy for Graves’ Disease

  • Yukiko YanoEmail author
  • Mitsuji Nagahama
  • Kiminori Sugino
  • Kunihiko Ito
  • Koichi Ito



Transient hypocalcemia is one of the postoperative complications of thyroidectomy for Graves’ disease, and perioperative parathyroid hormone (PTH) assays are used to predict postoperative hypocalcemia. We evaluated long-term changes in parathyroid function after surgery for Graves’ disease.


Serum PTH values were measured in Graves’ patients with postoperative hypocalcemia, and those patients were followed postoperatively.


Subtotal thyroidectomy was performed in 275 patients with Graves’ disease. Their serum calcium levels were measured on postoperative day (POD) 1, and patients with transient postoperative hypocalcemia were treated with calcium and vitamin D supplementation and followed up. The amount of calcium and vitamin D supplementation was adjusted to keep the patient’s serum calcium level within the normal range. Measurement of their serum intact PTH value on POD 1 revealed normal value in 18 patients, a below normal level in 22, and an above normal level in the other 2. During the follow-up period, the serum iPTH values remained normal in 12 patients, recovered to the normal level in 21 patients, and rose above the normal range in 9 patients. The serum iPTH values of all patients eventually reached the normal range during the follow-up period. A marked difference in preoperative serum alkaline phosphatase concentration was observed between the high-iPTH patients and the normocalcemic patients.


The phenomenon of an elevated serum PTH level after surgery for Graves’ disease was observed in 21% of the patients with postoperative hypocalcemia despite the achievement of normal serum calcium levels by calcium and vitamin D supplementation.


Serum Calcium Level Subtotal Thyroidectomy Serum iPTH Postoperative Hypocalcemia Transient Hypocalcemia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



We thank Dr. Kitagawa, Dr. Shibuya, Dr. Ohkuwa, Dr. Takayama, Dr. Suzuki, Dr. Akaishi, and Dr. Nakayama for assistance. Osu Shinryoujyo, Nagoya, Japan, is an associated hospital.


  1. 1.
    Wada JS, Goodall P, Deane L et al (1965) The course of partial parathyroid insufficiency after thyroidectomy. Br J Surg 52:497–503CrossRefGoogle Scholar
  2. 2.
    Escobar-Jimenez F, Torres EV, Picon A et al (1977) Hypocalcaemia and thyroid surgery. Lancet 2:402PubMedCrossRefGoogle Scholar
  3. 3.
    Wong C, Price S, Scott-Coombes D (2006) Hypocalcemia and parathyroid hormone assay following total thyroidectomy: predicting the future. World J Surg 30:825–832PubMedCrossRefGoogle Scholar
  4. 4.
    Lombardi CP, Raffaelli M, Princi P et al (2004) Early prediction of postthyroidectomy hypocalcemia by one single iPTH measurement. Surgery 136:1236–1241PubMedCrossRefGoogle Scholar
  5. 5.
    Dembinski TC, Yatscoff RW, Blandford DE (1994) Thyrotoxicosis and hungry bone syndrome—a cause of posttreatment hypocalcemia. Clin Biochem 27:69–74PubMedCrossRefGoogle Scholar
  6. 6.
    See AC, Soo KC (1997) Hypocalcaemia following thyroidectomy for thyrotoxicosis. Br J Surg 84:95–97PubMedCrossRefGoogle Scholar
  7. 7.
    Michie W, Stowes JM, Duncan T (1971) Mechanism of hypocalcemia after thyroidectomy for thyrotoxicosis. Lancet 1:508–513PubMedCrossRefGoogle Scholar
  8. 8.
    Yamashita H, Murakami T, Noguchi S et al (1999) Postoperative tetany in Graves disease: important role of vitamin D metabolites. Ann Surg 229:237–245PubMedCrossRefGoogle Scholar
  9. 9.
    Moriyama T, Yamashita H, Noguchi S et al (2005) Intraoperative parathyroid hormone assay in patients with Graves’ disease for prediction of postoperative tetany. World J Surg 29:1282–1287PubMedCrossRefGoogle Scholar
  10. 10.
    Kai M, Yamashita H, Cantor T et al (2008) Intraoperative parathyroid hormone levels measured by intact and whole parathyroid hormone assays in patients with Graves’ disease. Surg Today 38:214–221PubMedCrossRefGoogle Scholar
  11. 11.
    Sugino K, Ito K, Nagahama M et al (2008) Surgical management of Graves’ disease–10-year prospective trial at a single institution. Endocr J 55:161–167PubMedCrossRefGoogle Scholar
  12. 12.
    Beyer TD, Solorzano CC, Prinz RA et al (2007) Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism. Surgery 141:777–783PubMedCrossRefGoogle Scholar
  13. 13.
    Yen TW, Wilson SD, Krzywda EA et al (2006) The role of parathyroid hormone measurements after surgery for primary hyperparathyroidism. Surgery 140:665–672PubMedCrossRefGoogle Scholar
  14. 14.
    Carty SE, Roberts MM, Virji MA et al (2002) Elevated serum parathormone level after “concise parathyroidectomy” for primary sporadic hyperparathyroidism. Surgery 132:1086–1093PubMedCrossRefGoogle Scholar
  15. 15.
    Sato K (2006) Hungry bone syndrome. Nippon Rinsho Jun(Suppl 2):131–134Google Scholar
  16. 16.
    Vestergaard P, Mosekilde L (2003) Hyperthyroidism, bone mineral, and fracture risk—a meta-analysis. Thyroid 13:585–593PubMedCrossRefGoogle Scholar
  17. 17.
    Pantazi H, Papapetrou PD (2000) Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism. J Clin Endocrinol Metab 85:1099–106PubMedCrossRefGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2008

Authors and Affiliations

  • Yukiko Yano
    • 1
    Email author
  • Mitsuji Nagahama
    • 1
  • Kiminori Sugino
    • 1
  • Kunihiko Ito
    • 1
  • Koichi Ito
    • 1
  1. 1.Ito HospitalTokyoJapan

Personalised recommendations